GRM3
MOLECULAR TARGETglutamate metabotropic receptor 3
GRM3 (glutamate metabotropic receptor 3) is targeted by 7 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting GRM3
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | eglumetad | 3.04 | 20 |
| 2 | Glutamic Acid | 2.64 | 13 |
| 3 | Glutamic Acid | 2.64 | 13 |
| 4 | bdb whuutdbjxjrkmk | 2.20 | 8 |
| 5 | ly 379268 | 2.08 | 7 |
| 6 | bdb 2 amino bicyclo 2 1 1 hexane 2 5 dicarboxylic acid abhxd i chembl90501 | 0.69 | 1 |
| 7 | bdb chembl2112586 | 0.69 | 1 |
About GRM3 as a Drug Target
GRM3 (glutamate metabotropic receptor 3) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 7 compounds with documented GRM3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
GRM3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.